Alexander Röth

Alexander Röth's research focuses on rare blood disorders involving abnormal destruction of red blood cells and blood clotting problems, particularly paroxysmal nocturnal hemoglobinuria (PNH), cold agglutinin disease, aplastic anemia, and sickle cell disease. Much of the work involves clinical trials testing drugs that block or modulate the complement system, a part of the immune system that can mistakenly attack a patient's own blood cells, as well as studies on treatment safety, effectiveness, and patient-reported quality of life. This research is largely conducted through multi-site clinical trials and registries evaluating new and existing therapies for these conditions.

Publication output has grown substantially over the past decade, rising from single digits in 2017 to a sustained level of roughly 20-30 papers per year since 2023.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026